Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.4M
-
Number of holders
-
252
-
Total 13F shares, excl. options
-
107M
-
Shares change
-
-4.94M
-
Total reported value, excl. options
-
$3.5B
-
Value change
-
-$269M
-
Put/Call ratio
-
1.1
-
Number of buys
-
143
-
Number of sells
-
-142
-
Price
-
$32.63
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock (ACHC) as of Q4 2017
332 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock as of Q4 2017.
Acadia Healthcare Company, Inc. - Common Stock (ACHC) has 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 107M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (11M shares), BlackRock Inc. (10M shares), WELLINGTON MANAGEMENT GROUP LLP (8.77M shares), JPMORGAN CHASE & CO (7.21M shares), Vanguard Group Inc (6.77M shares), Aristotle Capital Management, LLC (6.18M shares), GOLDMAN SACHS GROUP INC (3.81M shares), Invesco Ltd. (3.18M shares), P2 Capital Partners, LLC (2.93M shares), and FRONTIER CAPITAL MANAGEMENT CO LLC (2.9M shares).
This table shows the top 252 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.